iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.04 (+5.67%)
At close: Nov 11, 2026 · 4:00 PM EST

iBio (IBIO) Short term Debt (2022 - 2025)

Updated

iBio (IBIO) reported Short term Debt of $16,000 for fiscal Q1 2026 (quarter ended Sep 30, 2025), down 91.2% from $182,000 a year earlier and down 75.0% from the prior quarter.

Analysis

iBio (IBIO) Short term Debt (2022 - 2025) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), iBio posted Short term Debt of $64,000, down 64.0% from FY2024.

  • By fiscal year, Short term Debt came in at $178,000 in FY2024 (+11.3%) and $160,000 in FY2023.
  • Per Business Quant data, the three fiscal quarters before Q1 2026 came in at $64,000 (Q4 2025), $110,000 (Q3 2025) and $155,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 iBio 118.23 Mn -174.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 16,000.00
Jun 30, 2025 64,000.00
Mar 31, 2025 110,000.00
Dec 31, 2024 155,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 178,000.00
Mar 31, 2024 173,000.00
Dec 31, 2023 168,000.00
Sep 30, 2023 164,000.00
Jun 30, 2023 160,000.00
Mar 31, 2023 156,000.00
Dec 31, 2022 152,000.00
API Access

iBio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=IBIO&period=max&api_key=YOUR_API_KEY